Abstract
The European Society for Human Reproduction and Embryology’s Special Interest Group Early Pregnancy recently published a revised terminology for the description of early pregnancy events as well as evidence-based guidelines for the investigation and medical treatment for patients with recurrent miscarriage (RM). This review, designed for clinicians working in the field of human reproduction, starts with the updated glossary of terms essential for an accurate assessment and documentation of clinical events. The revised terminology is summarized in this article. Many terms used in early pregnancy were old and had persisted before or since the introduction of ultrasound. Based on the data of recently published randomized controlled trials (RCTs) and meta-analysis, recommendations are provided for basic investigations of couples presenting with RM and for proposed therapies. The recommendations are likewise summarized in this article. A large number of therapies mentioned in the literature require more investigations under strict RCT conditions, whilst others are of no proven benefit or are associated with more harm than good.
Similar content being viewed by others
References
Farquharson RG, Jauniaux E, Exalto N (2005) Updated and revised nomenclature for decription of early pregnancy events. Hum Reprod 20:3008–3011
Royal College of Obstetricians and Gynaecologists (2006) The management of early pregnancy loss. Green-top Guideline, Nr 25. RCOG, London
Jauniaux E, Farquharson RG, Christiansen OB, Exalto N (2006) Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 21:2216–2222
O’Rahilly R, Muller F (2000) Prenatal ages and stages: measures and errors. Teratology 61:382–384
Pedersen JF (1982) Fetal crown rump length measurement by ultrasound in normal pregnancy. BJOG 89:926–930
O’Rahilly R (1986) The embryonic period. Teratology 34:119 (Letter)
Macklon NS, Geraedts JPM, Fauser BCJM (2002) Conception to ongoing pregnancy: the ‘black box’ of early pregnancy loss. Hum Reprod Updat 8:333–343
Condous G, Timmerman D, Goldstein S, Valentin L, Jurkovic D, Bourne T (2006) Pregnancies of unknown location: consensus statement. Ultrasound Obstet Gynecol 28:121–122
Jauniaux E, Kaminopetros P, El-Rafaey H (1999) Early pregnancy loss. In: Rodeck CH, Whittle MJ (eds) Fetal medicine. Churchill Livingstone, p 835–847
Chittacharoen A, Herabutya Y (2004) Slow fetal heart rate may predict pregnancy outcome in first-trimester threatened abortion. Fertil Steril 82:227–229
Duncan JM (1868) Researches in obstetrics. A & C Black, Edinburgh
Hutchon DJ, Cooper S (1997) Missed abortion versus delayed miscarriage. Br J Obstet Gynaecol 104:73
Brigham S, Conlon C, Farquharson RG (1999) A longitudinal study of pregnancy outcome following idiopathic recurring miscarriage. Hum Reprod 14:2868–2871
Bricker L, Farquharson RG (2002) Types of pregnancy loss in recurrent miscarriage: implications for research and clinical practice. Hum Reprod 17:1345–1350
Ugwumadu A, Manyonda I, Reid F, Hay P (2003) Effect of early oral clindamycin on late miscarriage and preterm delivery in asymptomatic women with abnormal vaginal flora and bacterial vaginosis: a randomized controlled trial. Lancet 361:983–988
Stirrat GM (1990) Recurrent miscarriage: definition and epidemiology. Lancet 336:673–675
Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M (2000) Maternal age and fetal loss: population-based register linkage study. BMJ 320:1708–1712
Christiansen OB, Nybo Andersen AM, Bosch E, Daya S, Delves PJ, Hviid TV, Kutteh WH, Laird SM, Li TC, van der Ven K (2005) Evidence-based investigations and treatments of recurrent pregnancy loss. Fertil Steril 83:821–839
Aplin JD, Hey NA, Li TC (1996) MUC1 as a cell surface and secretory component of endometrial epithelium: reduced levels in recurrent miscarriage. Am J Reprod Immunol 35:261–266
Quenby S, Vince G, Farquarson R, Aplin J (2002) Recurrent miscarriage: a defect in nature’s quality control? Hum Reprod 17:1959–1963
Stray-Pedersen B, Stray-Pedersen S (1984) Etiological factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol 148:140–146
Clifford K, Rai R, Regan L (1997) Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod 12:387–389
Jauniaux E, Burton GJ (2005) Pathophysiology of histological changes in early pregnancy loss. Placenta 26:114–123
Fox H (1993) Histological classification of tissue from spontaneous abortions: a valueless exercise? Histopathology 22:599–600
Hakvoort RA, Lisman BA, Boer K, Bleker OP, van Groningen K, van Wely M, Exalto N (2006) Histological classification of chorionic villous vascularization in early pregnancy. Hum Reprod 21:1291–1294
Morikawa M, Yamada H, Kato EH, Shimada S, Yamada T, Minakami H (2004) Embryo loss pattern is predominant in miscarriages with normal chromosome karyotype among women with repeated miscarriage. Hum Reprod 19:2644–2647
Ogasawara M, Aoki K, Okada S, Suzumori K (2000) Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril 73:300–304
Carp H, Toder V, Aviram A, Daniely M, Mashiach S, Barkai G (2001) Karyotype of the abortus in recurrent miscarriage. Fertil Steril 75:678–682
Stephenson MD, Awartini KA, Robinson WP (2002) Cytogenetic analysis of miscarriages from couples with recurring miscarriage: a case-control study. Hum Reprod 17:446–451
Braekeleer de M, Dao TN (1990) Cytogenetic studies in couples experiencing repeated pregnancy losses. Hum Reprod 5:519–528
Franssen MTM, Korevaar JC, Leschot NJ, Bossuyt PMM, Knegt AC, Gerssen-Schoorl KBJ, Wouters CH, Hansson KBM, Hochstenbach R, Madan K, van der Veen F, Goddijn M (2005) Selective chromosome analysis in couples with two or more miscarriages: case-control study. BMJ 331:137–139
Homer HA, Li TC, Cooke ID (2000) The septate uterus: a review of management and reproductive outcome. Fertil Steril 73:1–14
Salim R, Woelfer B, Backos M, Regan L, Jurkovic D (2003a) Reproducibility of three-dimension ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol 21:578–582
Woelfer B, Salim R, Banerjee S, Elson J, Regan L, Jurkovic D (2001) Reproductive outcome in women with congenital uterine anomalies detected by three-dimension ultrasound screening. Obstet Gynecol 98:1099–1103
Salim R, Regan L, Woelfer B, Backos M, Jurkovic D (2003b) A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod 28:162–166
Gianaroli L, Gordts S, D’Angelo A, Magli MC, Brosens I, Cetera C, Campo R, Ferraretti AP (2005) Effect of inner myometrium fibroid on reproductive outcome after IVF. Reprod Biomed Online 10:473–477
Royal College of Obstetricians and Gynaecologists (1998) The management of recurrent miscarriage. Guideline 1998; Nr 17. RCOG, London
Clifford K, Rai RS, Watson H, Franks S, Regan L (1996) Does suppressing luteinising hormone secretion reduce the miscarriage rate? Results of a randomised controlled trial. Br Med J 312:1508–1511
Lashen H, Fear K, Sturdee DW (2004) Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 19:1644–1646
Fedorcksac P, Dale PO, Storeng R, Tanbo T, Abyholm T (2001) The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 16:1086–1091
Bellver J, Rossal LP, Bosch E, Zuniga A, Corona JT, Melendez F, Gomez E, Simon C, Remohi J, Pellicer A (2003) Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 79:1136–1140
Palomba S, Orio F Jr, Falbo A, Manguso F, Russo T, Cascella T, Tolino A, Carmina E, Colao A, Zullo F (2005a) Prospective parallel randomized, double blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068–4074
Palomba S, Orio F Jr, Falbo A, Russo T, Tolino A, Zullo F (2005b) Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome. Fertil Steril 84:761–765
Thatcher SS, Jackson EM (2006) Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin. Fertil Steril 85:1002–1009
Oates-Whitehead RM, Hass DM, Carrier JAK (2005) Progestogen for preventing miscarriage. Cochrane Database Syst Rev 4:CD003511
Carmichael SL, Shaw GM, Laurent C, Croughan MS, Olney RS, Lammer EJ (2005) Maternal progestin intake and risk of hypospadias. Arch Pediatr Adolesc Med 159:957–962
Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, Brey R, Derksen R, Harris EN, Hughes GR, Triplett DA, Khamashta MA (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311
Kutteh WH (1996) Antoiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 174:1584–1589
Rai RS, Cohen H, Dave M, Regan L (1997) Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphopholipid antibodies). Br Med J 314:253–257
Farquharson RG, Quenby S, Greaves M (2002) Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol 100:408–413
Derksen RHWM, Khamashta MA, Branch DW (2004) Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 50:1028–1039
Empson M, Lassere M, Craig J, Scott J (2005) Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev 2:CD002859
Di Nisio M, Peters LW, Middeldorp S (2005) Anticoagulants for the treatement of recurrent pregnancy loss in women without antiphospholipid syndrome. Cochrane Database Syst Rev 2:CD004734
Rey E, Kahn SR, David M, Shrier I (2003) Thrombophilic disorders and fetal loss: a meta-analysis. Lancet 361:901–908
Dawood F, Farquharson R, Quenby S, Toh CH (2003) Acquired activated protein C resistance may be a risk factor for recurrent fetal loss. Fertil Steril 80:649–650
Roque H, Paidas MJ, Funai EF, Kuczynski E, Lockwood CJ (2004) Maternal thrombophilias are not associated with early pregnancy loss. Thromb Haemost 91:290–295
Carp H, Dolizky M, Tur-Kaspa I, Inbal A (2002) Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage. Fertil Steril 78:58–62
van Dunne FM, Doggen CJ, Heemskerk M, Rosendaal FR, Helmerhorst FM (2005) Factor V Leiden mutation in relation to fecundity and miscarriage in women with venous thrombosis. Hum Reprod 20:802–806
Jivraj S, Rai R, Underwood J, Regan L (2006) Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod 21:1161–1165
Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GDO, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA (2006) Thrombophilia in pregnancy: a systematic review. The thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Br J Haematol 132:171–196
Nelen WLDM, Blom HK, Steegers EAP, den Heijer M, Eskes TKAB (2000) Hyperhomocysteinemia and recurrent early pregnancy loss: a meta-analysis. Fertil Steril 74:1196–1199
Makris M (2000) Hyperhomocysteinemia and thrombosis. Clin Lab Haematol 22:133–143
George L, Mills JL, Johansson AL, Nordmark A, Olander B, Granath F, Cnattingius S (2002) Plasma folate levels and risk of spontaneous abortion. JAMA 288:1867–1873
Laird SM, Tukerman EM, Cork BA, Linjawi S, Blakemore AIF, Li TC (2003) A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Updat 9:163–174
Moffett A, Regan L, Braude P (2004) Natural killer cells, miscarriage, and infertility. BMJ 329:1283–1285
Wold AS, Arici A (2005) Natural killer cells and reproductive failure. Curr Opin Obstet Gynecol 17:237–241
Rai R, Sacks G, Trew G (2005) Natural killer cells and reproductive failure, practice and prejudice. Hum Reprod 20:1123–1126
Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G (2005) Prednisolone reduces preconceptual natural killer cells in women with recurrent miscarriage. Fertil Steril 84:980–984
Kruse C, Rosgaard A, Steffensen R, Varming K, Jensenius JC, Christiansen OB (2002) Low serum level of mannan-binding lectin is a determinant for pregnancy outcome in women with recurrent spontaneous abortion. Am J Obstet Gynecol 187:1313–1320
Christiansen OB, Nielsen HS, Pedersen B (2004) Active or passive immunization in unexplained recurrent miscarriage. J Reprod Immunol 62:41–51
Christiansen OB, Nielsen HS (2005) Intravenous immunoglobulin in the prevention of recurrent miscarriage: does it work? Chem Immunol Allergy 88:117–127
Porter TF, LaCoursiere YL, Scott JR (2006) Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev
Simpson JL, Mills JL, Lee J, Holmes JB, Kim H, Metzger B, Knopp R, Jovanovic-Peterson L, Aarons J, Conley M (1996) Infectious processes: an infrequent cause of first trimester spontaneous abortions. Hum Reprod 11:668–672
Li TC, Makris M, Tomsu M, Tuckerman E, Laird S (2002) Recurrent miscarriage: aetiology, management and prognosis. Hum Reprod Updat 8:463–481
Gardella JR, Hill JA (2000) Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med 18:407–424
Rumbold A, Middleton P, Crowther CA (2005) Vitamin supplementation for preventing miscarriage. Cochrane Database Syst Rev 2:CD004073
Clark AM, Thornley B, Tomlinson L, Gattetley C, Norman RJ (1998) Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment. Hum Reprod 13:1502–1505
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Exalto, N., Christiansen, O.B., Farquharson, R.G. et al. Early pregnancy failure: a review. Eur Clinics Obstet Gynaecol 2, 171–179 (2006). https://doi.org/10.1007/s11296-006-0050-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11296-006-0050-9